Celecoxib: a new option in the treatment of arthropathies and familial adenomatous polyposis

Author： Davies N.M. Gudde T.W. de Leeuw M.A.

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.2, Iss.1, 2001-01, pp. : 139-152

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Preimplantation genetic diagnosis of familial adenomatous polyposis

By Davis T Song B Cram DS

Reproductive BioMedicine Online, Vol. 13, Iss. 5, 2006-11 ,pp. : 707-711

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Colon-specific delivery of celecoxib is a potential strategy to improve toxicological and pharmacological properties of the selective Cox-2 inhibitor: implication in treatment of familiar adenomatous polyposis

By Lee Yonghyun Kim Hyunjeong Kim Wooseong Yoon Jeong-Hyun Jeong Seong Hoon Jung Yunjin

Journal of Drug Targeting, Vol. 20, Iss. 6, 2012-07 ,pp. : 524-534

Informa Healthcare

Access to resources Recommend Favorite

Lisdexamfetamine dimesylate: a new option in stimulant treatment for ADHD

By Dew Rachel E Kollins Scott H

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 17, 2010-12 ,pp. : 2907-2913

Informa Healthcare

Access to resources Recommend Favorite

Perifosine – a new option in treatment of acute myeloid leukemia?

By Krawczyk Janusz Keane Niamh Swords Ronan O'Dwyer Michael Freeman Ciara L Giles Francis J

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 10, 2013-10 ,pp. : 1315-1327

Informa Healthcare

Access to resources Recommend Favorite

Familial Hypercholesterolemia: Etiology, Diagnosis and New Treatment Options

Current Pharmaceutical Design, Vol. 20, Iss. 40, 2014-12 ,pp. : 6220-6229

Bentham Science Publishers

Access to resources Recommend Favorite